Brazil, Russia, India, China and South Africa account for half of the world’s tuberculosis cases, but only South Africa’s president will attend today’s (September 26th) first United Nations high-level meeting on TB.
After feeling ill for months, 16-year-old Sinethemba Kuse received the news that she had multi-drug-resistant tuberculosis (MDR-TB) from her local clinic in Khayelitsha outside of Cape Town in December last year.
Government’s small-scale introduction of the first new TB drug in four decades is saving lines and paving the way for more, better and cheaper drugs to treat drug-resistant TB. Many wonder if they will come fast enough for those who need them.
Developed by the independent AIDS research and policy US-based think tank, the Treatment Action Group (TAG), the 32-page guide outlines tuberculosis (TB) drugs currently in use around the world.